Literature DB >> 30429439

Metabolism of Natural Highly Unsaturated Fatty Acid, Tetracosahexaenoic Acid (24:6n-3), in C57BL/KsJ-db/db Mice.

Naohiro Gotoh1, Koji Nagao2, Hiroki Ishida1, Kazusa Nakamitsu2, Kazuaki Yoshinaga3, Toshiharu Nagai3, Fumiaki Beppu1, Aya Yoshinaga-Kiriake1, Hiroyuki Watanabe4, Teruyoshi Yanagita5.   

Abstract

Tetracosahexaenoic acid (THA; 24:6n-3) is a natural, n-3 highly unsaturated fatty acid (n-3HUFA) that exists in fish, including Baltic herring (Clupea harengus) and the flathead flounder (Hippoglossoides dubius). In this study, natural n-3HUFAs, i.d. eicosapentaenoic acid (EPA, 20:5n-3), docosahexaenoic acid (DHA, 22:6n-3), and THA were administrated to C57BL/KsJ-db/db mice for 4 weeks and the liver and serum lipid profiles, hepatic enzyme activity, expression of mRNA related to lipid metabolism, and adiponectin serum levels were then analyzed. The results showed that THA had the highest activity in suppressing hepatic triglyceride (TG) accumulation and increase in liver weight among the test groups. Furthermore, THA increased adiponectin levels in serum. These results indicate that THA is an excellent natural n-3HUFA that can suppress the development of metabolic syndromes and circulatory system diseases. The order of the n-3HUFA activity was THA > DHA > EPA in almost all the factors examined here. In a previous study of ours, the order was DHA > DPA > EPA, so the final order was summarized as THA > DHA > DPA > EPA. This order clearly translates to the rule that "the number of double bonds and carbon atoms in the n-3HUFA structure relates to their clinical functions".

Entities:  

Keywords:  tetracosahexaenoic acid; C57BL/KsJ-db/db mice; docosahexaenoic acid; eicosapentaenoic acid; function; n-3 polyunsaturated fatty acid

Mesh:

Substances:

Year:  2018        PMID: 30429439     DOI: 10.5650/jos.ess18167

Source DB:  PubMed          Journal:  J Oleo Sci        ISSN: 1345-8957            Impact factor:   1.601


  3 in total

1.  Tetracosahexaenoylethanolamide, a novel N-acylethanolamide, is elevated in ischemia and increases neuronal output.

Authors:  Lin Lin; Adam H Metherel; Mathieu Di Miceli; Zhen Liu; Cigdem Sahin; Xavier Fioramonti; Carolyn L Cummins; Sophie Layé; Richard P Bazinet
Journal:  J Lipid Res       Date:  2020-08-21       Impact factor: 5.922

2.  Metabolomic and Microbial Remodeling by Shanmei Capsule Improves Hyperlipidemia in High Fat Food-Induced Mice.

Authors:  Lijing Du; Qian Wang; Shuai Ji; Yuanfang Sun; Wenjing Huang; Yiping Zhang; Shasha Li; Shikai Yan; Huizi Jin
Journal:  Front Cell Infect Microbiol       Date:  2022-04-27       Impact factor: 6.073

3.  Alteration in plasma docosahexaenoic acid levels following oral administration of ethyl icosapentate to rats.

Authors:  Mayu Onozato; Yukina Okanishi; Misumi Akutsu; Ikumi Okumura; Aina Nemoto; Kyosuke Takano; Tatsuya Sakamoto; Hideaki Ichiba; Takeshi Fukushima
Journal:  Pract Lab Med       Date:  2019-10-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.